| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |